Table 1 Clinical characteristics of batch 1 and batch 2 of case–control subjects that contributed to the blood gene-chip profiles analyzed and presented in Figs. 4 and 5
From: A novel multi-tissue RNA diagnostic of healthy ageing relates to cognitive health status
Gender and age-matched cohorts | Age | Gender (F/M) | MMSE | CDR-SOB |
|---|---|---|---|---|
Batch 1 | Â | Â | Â | Â |
ControlMCI (n = 67) | 69.6 (±4.2) | 41/26 (61 % F) | 29.1 (±1.2) | 0.07 (±0.18) |
MCI (n = 39) | 70.0 (±3.3) | 24/15 (62 % F) | 27.5 (±1.6) | 1.24 (±1.60) |
ControlAD (n = 64) | 70.2 (±3.7) | 41/23 (64 % F) | 29.1 (±1.2) | 0.08 (±0.18) |
AD (n = 49) | 69.8 (±4.4) | 34/15 (69 % F) | 21.8 (±4.5) | 5.44 (±2.95) |
Batch 2 | Â | Â | Â | Â |
ControlMCI (n = 71) | 70.8 (±2.9) | 44/27 (62 % F) | 28.9 (±1.9) | 0.15 (±0.57) |
MCI (n = 31) | 69.5 (±4.5) | 23/8 (74 % F) | 27.6 (±1.9) | 1.34 (±1.86) |
ControlAD (n = 71) | 70.8 (±2.9) | 44/27 (62 % F) | 28.9 (±1.9) | 0.15 (±0.57) |
AD (n = 40) | 69.9 (±4.3) | 23/17 (58 % F) | 21.0 (±5.6) | 5.80 (±2.75) |